We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+1.02%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$12.6B
AUM Growth
-$409M
Cap. Flow
-$304M
Cap. Flow %
-2.41%
Top 10 Hldgs %
25.36%
Holding
834
New
37
Increased
442
Reduced
281
Closed
71

Top Sells

Rank Stock Value
1
CMI icon
Cummins
CMI
+$78.5M
2
FNV icon
Franco-Nevada
FNV
+$57.5M
3
AEM icon
Agnico Eagle Mines
AEM
+$54.9M
4
DIS icon
Walt Disney
DIS
+$41.1M
5
AMAT icon
Applied Materials
AMAT
+$40.3M

Sector Composition

Rank Sector Weight
1 Materials 38.92%
2 Energy 24.99%
3 Healthcare 9.19%
4 Industrials 4.38%
5 Technology 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSN icon
76
Tyson Foods
TSN
$21.5B
$39.9M 0.32%
749,015
-254,535
-25% -$12.2M
ESV
77
DELISTED
Ensco Rowan plc
ESV
$39.1M 0.31%
634,444
+15,148
+2% +$990K
AG icon
78
First Majestic Silver
AG
$7.52B
$37.1M 0.29%
11,344,811
+3,435,936
+43% +$11.7M
CSX icon
79
CSX Corp
CSX
$94B
$36.3M 0.29%
4,201,368
+124,068
+3% +$1.13M
RTX icon
80
RTX Corp
RTX
$290B
$36.2M 0.29%
598,678
-60,582
-9% -$3.67M
VAR
81
DELISTED
Varian Medical Systems, Inc.
VAR
$36M 0.29%
507,539
+507,010
+95,843% +$35M
EMR icon
82
Emerson Electric
EMR
$81.6B
$35.8M 0.28%
747,531
-68,019
-8% -$3.24M
OII icon
83
Oceaneering
OII
$4.64B
$35.4M 0.28%
942,847
+104,672
+12% +$4.48M
IBM icon
84
IBM
IBM
$213B
$35.3M 0.28%
+268,187
New +$36M
SE
85
DELISTED
Spectra Energy Corp Wi
SE
$35.3M 0.28%
1,473,389
+1,463,967
+15,538% +$38.9M
ALXN
86
DELISTED
Alexion Pharmaceuticals
ALXN
$35.2M 0.28%
184,376
-6,587
-3% -$1.15M
BRK.B icon
87
Berkshire Hathaway Class B
BRK.B
$1.1T
$35.1M 0.28%
265,927
-23,502
-8% -$3.15M
VFC icon
88
VF Corp
VFC
$5.92B
$34.9M 0.28%
595,332
+593,597
+34,213% +$37.1M
AXP icon
89
American Express
AXP
$224B
$34.9M 0.28%
+501,366
New +$36.5M
HOG icon
90
Harley-Davidson
HOG
$2.61B
$34.5M 0.27%
+759,112
New +$37.4M
KSU
91
DELISTED
Kansas City Southern
KSU
$34.4M 0.27%
+460,194
New +$39.3M
BMRN icon
92
BioMarin Pharmaceuticals
BMRN
$11.9B
$33.8M 0.27%
322,817
+71,513
+28% +$7.47M
TFCFA
93
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$33.8M 0.27%
1,244,679
-188,117
-13% -$5.46M
REGN icon
94
Regeneron Pharmaceuticals
REGN
$72.9B
$33.5M 0.27%
61,693
-7,071
-10% -$3.83M
WU icon
95
Western Union
WU
$2.53B
$33.3M 0.26%
1,858,994
-214,324
-10% -$4.05M
TWX
96
DELISTED
Time Warner Inc
TWX
$33.2M 0.26%
512,812
-26,293
-5% -$1.84M
ILMN icon
97
Illumina
ILMN
$29.5B
$32.6M 0.26%
174,696
+4,162
+2% +$672K
BXLT
98
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$32.1M 0.25%
821,812
-132,530
-14% -$4.62M
TSM icon
99
TSMC
TSM
$1.94T
$31.9M 0.25%
1,400,139
+228,189
+19% +$5.13M
PII icon
100
Polaris
PII
$3.83B
$31.8M 0.25%
369,541
+73,112
+25% +$7.75M

Similar funds

VanEck Associates's Q4 2015 Portfolio in Review

As of Q4 2015, VanEck Associates held 834 positions worth $12.6B, down 3.1% from $13B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

VanEck Associates's Q4 2015 filing shows 37 new, 442 increased, 281 reduced and 71 closed positions. Its largest new stake was Kansas City Southern: 460,194 shares worth $34.4M. The largest sale was Cummins, an estimated $78.5M.

By sector, the portfolio is most concentrated in Materials at 39% of assets, down from 40% a quarter earlier, followed by Energy and Healthcare.

  • VanEck Associates's largest Q4 2015 buy was Kansas City Southern: 460,194 shares worth $34.4M.
  • VanEck Associates added most to CF Industries in Q4 2015, an estimated $88.6M increase.
  • VanEck Associates's biggest Q4 2015 reduction was Cummins, cutting an estimated $78.5M.
  • VanEck Associates fully exited Procter & Gamble in Q4 2015, selling an estimated $39.7M.
  • VanEck Associates's ten largest holdings make up 25% of its $12.6B portfolio in Q4 2015.
  • VanEck Associates opened 37 new positions and closed 71 in Q4 2015.
  • VanEck Associates's portfolio value fell 3.1% quarter-over-quarter to $12.6B.

Based on VanEck Associates's 13F filing for Q4 2015, filed 12 Feb 2016.